Redwire Pioneering Biopharma Production in Space by Successfully Bioprinting Live Human Heart Tissue and Delivering Second Batch of PIL-BOX Pharmaceutical Crystal Experiments
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240507667003/en/
![Live human heart tissue bioprinted with Redwire's BioFabrication Facility onboard the International Space Station. The tissue successfully returned to Earth in April 2024. Image: Redwire](https://mms.businesswire.com/media/20240507667003/en/2124005/4/Heart_Tissue.jpg)
Live human heart tissue bioprinted with
Redwire’s space biotech capabilities are creating valuable opportunities for the biopharma industry as microgravity allows for outcomes that aren’t possible on Earth, including bioprinting materials that form and hold a three-dimensional shape without the use of scaffolds or additional chemical support. It is also possible to grow larger and more-highly-ordered pharmaceutical crystals in microgravity. Understanding crystal growth and design can inform the entire drug discovery, development, and design process for small molecule and large biomolecule pharmaceuticals as companies look to deliver new, optimized treatments to help patients.
“These are extraordinary scientific achievements that bring us closer to reliable, large-scale commercial biotech services on-orbit,” said
Live human heart tissue bioprinted on Redwire’s BFF could eventually be used to create heart patches as a treatment for damaged heart tissue and opens the door to more effective, personalized medicine. The tissue sample is now undergoing further testing at Redwire’s facility in
Redwire’s second batch of returned PIL-BOX experiments comprised of 36 crystal experiments, which included various crystal molecules designed for pharmaceutical use, with antiviral, antifungal, and antiseizure applications. These returned crystal experiments were led by
The PIL-02 and PIL-03 investigations have validated Redwire’s ability to consistently provide pharmaceutical researchers with a reliable platform to manufacture a variety of crystals in space and bring them down quickly in a repeatable and scalable process.
BFF and PIL-BOX are part of Redwire’s expansive array of space biotech and microgravity development platforms that make use of the space environment to improve life on Earth.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20240507667003/en/
Emily.Devine@redwirespace.com
305-632-9137
OR
Investors:
investorrelations@redwirespace.com
904-425-1431
Source: